Article
Identification of genes affecting the toxicity of anti-cancer drug bortezomib by genome-wide screening in S. pombe.
PloS one - 1 Jan 2011
Takeda Kojiro, Mori Ayaka, Yanagida Mitsuhiro
Abstract excerpt
Bortezomib/PS-341/Velcade, a proteasome inhibitor, is widely used to treat multiple myeloma. While several mechanisms of the cytotoxicity of the drug were proposed, the actual mechanism remains elusive. We aimed to identify genes affecting the cytotoxicity of Bortezomib in the fission yeast S. pombe as the drug inhibits this organism's cell division cycle like proteasome mutants. Among the 2815 genes screened...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
